Mechanistic investigation suggests that GALNT1 modifies EGFR O-glycosylation, thereby, regulating EGFR phosphorylation, internalization and degradation, which in turn modulates HCC cell malignant behaviors. Here, EGFR is linked to hepatocellular carcinoma.